Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Bioorg Med Chem. 2022 Oct 4;73:117043. doi: 10.1016/j.bmc.2022.117043

Figure 2.

Figure 2.

Dose-response curves of compounds tested in SH-SY5Y (A, B), SK-N-AS (C, D) and HT-1080 (E). Control compounds crizotinib IC50 0.92 μM in SH-SY5Y and IC50 12.12 μM in SK-N-AS and entrectinib IC50 1.60 in SH-SY5Y and IC50 4.47 μM in SK-N-AS.